Literature DB >> 29394133

MiR-200c-3p inhibits cell migration and invasion of clear cell renal cell carcinoma via regulating SLC6A1.

Naibijiang Maolakuerban1, Baihetiya Azhati1, Hamulati Tusong1, Asimujiang Abula1, Anniwaer Yasheng1, Ayiding Xireyazidan1.   

Abstract

In this study, we investigated the mechanism of miR-200c-3p and SLC6A1 in regulating cell activity of clear cell renal cell carcinoma (CCRCC). The mRNA and miRNA expressions of tissue specimens were analyzed by CapitalBio Corporation (Beijing, China). The expression of SLC6A1 in CCRCC cells was examined through qRT-PCR and western blot. The migration and invasion ability of 786-O cells was testified by transwell assay after transfected. 786-O cell proliferation ability was detected by MTT assay. Dual luciferase reporter assay verified the association between SLC6A1 and miR-200c-3p. SLC6A1 was high expressed and miR-200c-3p was low expressed in CCRCC tissues and cells. Besides, lower SLC6A1 expression indicated longer survival time and higher survival rate. MiR-200c-3p could directly target at SLC6A1 and reduce its expression. MiR-200c-3p inhibited the proliferation, migration and invasion in 786-O cells by down-regulating SLC6A1 expression. The results suggested that the miR-200c-3p served as a suppressor for CCRCC via down-regulating SLC6A1.

Entities:  

Keywords:  SLC6A1; clear cell renal cell carcinoma; invasion; miR-200c-3p; migration; survival rate

Mesh:

Substances:

Year:  2018        PMID: 29394133      PMCID: PMC5902236          DOI: 10.1080/15384047.2017.1394551

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  35 in total

1.  Prognostic value of candidate microRNAs in gastric cancer: A validation study.

Authors:  Lan Zhang; Zebo Huang; Huo Zhang; Mingxia Zhu; Wei Zhu; Xin Zhou; Ping Liu
Journal:  Cancer Biomark       Date:  2017       Impact factor: 4.388

2.  A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.

Authors:  Hendrik Van Poppel; Luigi Da Pozzo; Walter Albrecht; Vsevolod Matveev; Aldo Bono; Andrzej Borkowski; Jean-Marie Marechal; Laurence Klotz; Eila Skinner; Thomas Keane; Ilse Claessens; Richard Sylvester
Journal:  Eur Urol       Date:  2006-11-15       Impact factor: 20.096

Review 3.  GABA transporter GAT1: a crucial determinant of GABAB receptor activation in cortical circuits?

Authors:  Guillermo Gonzalez-Burgos
Journal:  Adv Pharmacol       Date:  2010

Review 4.  State of the science: an update on renal cell carcinoma.

Authors:  Eric Jonasch; P Andrew Futreal; Ian J Davis; Sean T Bailey; William Y Kim; James Brugarolas; Amato J Giaccia; Ghada Kurban; Armin Pause; Judith Frydman; Amado J Zurita; Brian I Rini; Pam Sharma; Michael B Atkins; Cheryl L Walker; W Kimryn Rathmell
Journal:  Mol Cancer Res       Date:  2012-05-25       Impact factor: 5.852

5.  Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy.

Authors:  Senthil Karunakaran; Nagavedi S Umapathy; Muthusamy Thangaraju; Takahiro Hatanaka; Shiro Itagaki; David H Munn; Puttur D Prasad; Vadivel Ganapathy
Journal:  Biochem J       Date:  2008-09-15       Impact factor: 3.857

6.  [Gene expression profiling using oligonucleotide microarray in atrophic gastritis and intestinal metaplasia].

Authors:  Kyong Rae Kim; Soo Youn Oh; Ung Chae Park; Joon Ho Wang; Jae Dong Lee; Hyuk Jung Kweon; Sang Yoon Kim; Seung Hwa Park; Dong Kug Choi; Chan Gil Kim; Seongc Ho Choi
Journal:  Korean J Gastroenterol       Date:  2007-04

7.  microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.

Authors:  Xuegang Wang; Xuanyu Chen; Rong Wang; Pei Xiao; Zhenghong Xu; Li Chen; Weiwei Hang; Anming Ruan; Hongmei Yang; Xiaoping Zhang
Journal:  Oncol Rep       Date:  2013-06-07       Impact factor: 3.906

8.  Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.

Authors:  Hirofumi Yoshino; Hideki Enokida; Toshihiko Itesako; Shuichi Tatarano; Takashi Kinoshita; Miki Fuse; Satoko Kojima; Masayuki Nakagawa; Naohiko Seki
Journal:  J Hum Genet       Date:  2013-05-02       Impact factor: 3.172

9.  miR-155 regulates the proliferation and invasion of clear cell renal cell carcinoma cells by targeting E2F2.

Authors:  Yu Gao; Xin Ma; Yuanxin Yao; Hongzhao Li; Yang Fan; Yu Zhang; Chaofei Zhao; Lei Wang; Minghui Ma; Zhengwei Lei; Xu Zhang
Journal:  Oncotarget       Date:  2016-04-12

10.  Growth-induced stress enhances epithelial-mesenchymal transition induced by IL-6 in clear cell renal cell carcinoma via the Akt/GSK-3β/β-catenin signaling pathway.

Authors:  Q Chen; D Yang; H Zong; L Zhu; L Wang; X Wang; X Zhu; X Song; J Wang
Journal:  Oncogenesis       Date:  2017-08-28       Impact factor: 7.485

View more
  20 in total

1.  MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2.

Authors:  Ying Liu; Yong Zhang; Qiubo Li; Ruiqi Xu; Nian Huang
Journal:  Thorac Cancer       Date:  2022-05-22       Impact factor: 3.223

2.  Exosomes from normal and diabetic human corneolimbal keratocytes differentially regulate migration, proliferation and marker expression of limbal epithelial cells.

Authors:  Aleksandra Leszczynska; Mangesh Kulkarni; Alexander V Ljubimov; Mehrnoosh Saghizadeh
Journal:  Sci Rep       Date:  2018-10-11       Impact factor: 4.379

3.  Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer.

Authors:  Chaojiang Chen; Zhiduan Cai; Yangjia Zhuo; Ming Xi; Zhuoyuan Lin; Funeng Jiang; Zezhen Liu; Yueping Wan; Yu Zheng; Jianxin Li; Xing Zhou; Jianguo Zhu; Weide Zhong
Journal:  BMC Cancer       Date:  2020-04-06       Impact factor: 4.430

4.  EZH2 facilitates BMI1-dependent hepatocarcinogenesis through epigenetically silencing microRNA-200c.

Authors:  Leibo Xu; Junlong Lin; Wanyu Deng; Weixin Luo; Yipei Huang; Chao-Qun Liu; Fa-Peng Zhang; Yu-Fei Qin; Ping-Pui Wong; Chao Liu
Journal:  Oncogenesis       Date:  2020-11-09       Impact factor: 7.485

5.  Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p.

Authors:  Jinglin Li; Canghai Guan; Zengtao Hu; Lang Liu; Zhilei Su; Pengcheng Kang; Xingming Jiang; Yunfu Cui
Journal:  Hum Cell       Date:  2020-10-10       Impact factor: 4.174

6.  MiR-200c-3p increased HDMEC proliferation through the notch signaling pathway.

Authors:  Xianyu Hu; Suwen Bai; Lingyi Li; Pengfei Tian; Sun Wang; Ning Zhang; Bing Shen; Juan Du; Shengxiu Liu
Journal:  Exp Biol Med (Maywood)       Date:  2021-01-20

7.  SLC6A1-miR133a-CDX2 loop regulates SK-OV-3 ovarian cancer cell proliferation, migration and invasion.

Authors:  Yuan Zhao; Xiaokui Zhou; Yangyan He; Changjun Liao
Journal:  Oncol Lett       Date:  2018-08-07       Impact factor: 2.967

8.  The SOD Mimic MnTnHex-2-PyP5+ Reduces the Viability and Migration of 786-O Human Renal Cancer Cells.

Authors:  João G Costa; Nuno Saraiva; Ines Batinic-Haberle; Matilde Castro; Nuno G Oliveira; Ana S Fernandes
Journal:  Antioxidants (Basel)       Date:  2019-10-17

9.  Long Noncoding RNA PTPRG Antisense RNA 1 Reduces Radiosensitivity of Nonsmall Cell Lung Cancer Cells Via Regulating MiR-200c-3p/TCF4.

Authors:  Qiang Ma; Rungui Niu; Wei Huang; Liangshan Da; Yanlei Tang; Daowen Jiang; Yanfeng Xi; Congjun Zhang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

10.  A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database.

Authors:  Mingjun Wang; Rongjing Li; Xiuhe Zou; Tao Wei; Rixiang Gong; Jingqiang Zhu; Zhihui Li
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.